Review 10.1172/JCI122955
1Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
2Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, United Kingdom.
3Institute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Institute of Experimental Biomedicine, University Hospital and Rudolf Virchow Centre, University of Würzburg, Josef-Schneider-Str 2, 97080 Würzburg, Germany. Phone: 49.931.31.80405; Email: bernhard.nieswandt@virchow.uni-wuerzburg.de. Or to: Steve P. Watson, Institute of Cardiovascular Sciences, IBR Building, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom. Phone: 44.121.4146514, Email: s.p.watson@bham.ac.uk.
Find articles by
Rayes, J.
in:
JCI
|
PubMed
|
Google Scholar
|
1Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
2Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, United Kingdom.
3Institute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Institute of Experimental Biomedicine, University Hospital and Rudolf Virchow Centre, University of Würzburg, Josef-Schneider-Str 2, 97080 Würzburg, Germany. Phone: 49.931.31.80405; Email: bernhard.nieswandt@virchow.uni-wuerzburg.de. Or to: Steve P. Watson, Institute of Cardiovascular Sciences, IBR Building, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom. Phone: 44.121.4146514, Email: s.p.watson@bham.ac.uk.
Find articles by
Watson, S.
in:
JCI
|
PubMed
|
Google Scholar
|
1Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
2Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, United Kingdom.
3Institute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
Address correspondence to: Bernhard Nieswandt, Institute of Experimental Biomedicine, University Hospital and Rudolf Virchow Centre, University of Würzburg, Josef-Schneider-Str 2, 97080 Würzburg, Germany. Phone: 49.931.31.80405; Email: bernhard.nieswandt@virchow.uni-wuerzburg.de. Or to: Steve P. Watson, Institute of Cardiovascular Sciences, IBR Building, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom. Phone: 44.121.4146514, Email: s.p.watson@bham.ac.uk.
Find articles by Nieswandt, B. in: JCI | PubMed | Google Scholar
First published January 2, 2019 - More info
Although platelets are best known for their role in hemostasis, they are also crucial in development, host defense, inflammation, and tissue repair. Many of these roles are regulated by the immune-like receptors glycoprotein VI (GPVI) and C-type lectin receptor 2 (CLEC-2), which signal through an immunoreceptor tyrosine–based activation motif (ITAM). GPVI is activated by collagen in the subendothelial matrix, by fibrin and fibrinogen in the thrombus, and by a remarkable number of other ligands. CLEC-2 is activated by the transmembrane protein podoplanin, which is found outside of the vasculature and is upregulated in development, inflammation, and cancer, but there is also evidence for additional ligands. In this Review, we discuss the physiological and pathological roles of CLEC-2 and GPVI and their potential as targets in thrombosis and thrombo-inflammatory disorders (i.e., disorders in which inflammation plays a critical role in the ensuing thrombosis) relative to current antiplatelet drugs.
A subscription is required for you to read this article in full. If you are a subscriber, you may sign in to continue reading.
Click here to sign into your account.
Please select one of the subscription options, which includes a low-cost option just for this article.
If you are at an institution or library and believe you should have access, please check with your librarian or administrator (more information).
Please try these troubleshooting tips.